ClinicalTrials.Veeva

Menu

Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'Ivoire (VIRAGE+)

A

ANRS, Emerging Infectious Diseases

Status

Active, not recruiting

Conditions

Insulin Resistance Syndrome X
Cardiovascular Diseases
HIV Infections

Treatments

Behavioral: Physical activity programme
Behavioral: Home-based physical activity

Study type

Interventional

Funder types

Other

Identifiers

NCT06139497
ANRS 0396 VIRAGE+

Details and patient eligibility

About

The overall objective of this research is to provide evidence on the effectiveness and implementation of two strategies deliver a structured programme of physical activity (PA) people living with HIV older than 50 years from Ivory Coast.

The research will starts a baseline formative research including people with and without HIV infection.

Participants are randomized 1:1:1 to one for the following group: (1) a reference arm receiving a group-based PA program supervised by a coach (n = 60), (2) an exploratory arm receiving a home-based PA program with remote supervision via phone calls and messaging apps (n = 60) and (3) a control arm receiving health education sessions (n = 60). The total follow-up period is 12 months, with an initial 6-month active phase and then a 6-month maintenance.

The primary effectiveness outcome is the improvement at the 6-minute step-up test between baseline and 6 months. Secondary outcomes include changes in performance on other functional tests and improvement of cardio-metabolic risk factors. Implementation outcomes include acceptability, adoption, feasibility and sustainability of the intervention.Implementation outcomes will be assessed using mixed methods during the intervention. Effectiveness outcomes and patient-centered outcomes will be assessed at baseline, 6 and 12 months.

Full description

This is is a prospective, randomised, pilot trial with two phases: a 6-month active phase to implement the intervention and a 6-month maintenance phase to evaluate the sustainability of the intervention's effects. This study adopts a type II hybrid design assessing both the effectiveness of the intervention and the implementation outcomes to identify factors influencing its adoption by users, as well as its integration into healthcare practices

It starts with a baseline research combining a cross-sectional study and a qualitative formative research. The cross-sectional study comprises clinical evaluations, functional tests, as well as quantitative evaluations by questionnaire of disability (WHODAS, HDQ) and depression (PHQ-9). It includes 300 people living wiht HIV (PLHIV) receiving antiretroviral therapy and followed at the Avocatier health facility (FSU) and the El Rapha medical health centre (CMS), in the Abobo district, Abidjan. A comparison group of adults without HIV infection of similar sex and age distribution is included as a reference group (n = 150).

The qualitative research explores how the practice of physical activity is perceived culturally and socially and to determine the factors that may influence the implementation of this type of activity.

The intervention consists of a 48-week exercise programme including aerobic, resistance, balance and flexibility exercises twice to three times a week for at least 60 minutes. Two delivery approaches for the exercise programme are proposed. In the group-based arm, participants are invited to participate in group sessions directly supervised by a coach. The other sessions are unsupervised. During the first 24 weeks (active phase), the supervised group sessions are scheduled on a weekly basis while they are more spaced out, on a monthly basis, during the second part of the 48 weeks (maintenance phase). In the home-based arm, participants have to perform the same exercise programme at home. Participants are contacted by phone by a study staff every week to review the activities performed, collect information on their adherence to and perception of the programme and to provide positive feedback, help to addess challenges and reinforce their motivation. Participants of the control group are offered monthly health education sessions and a delayed participation to the programme.

Enrollment

180 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Eligibility criteria for the intervention :

Inclusion criteria:

  • Age ≥50 years

  • Documented HIV infection.

  • Receiving antiretroviral therapy for ≥ 12 months.

  • Residing in the Abobo district (Côte d'Ivoire).

  • Presence of at least one functional limitation or disability criterion among the following:

    • Performance in the 6-minute walk test ≤ 300 m.
    • Handgrip strength ≤ 35 kg for men or ≤ 24 kg for women.
    • WHODAS score ≥ 10.
    • SPPB score between 4 and 9.
  • Signed informed consent.

Exclusion criteria

  • Medical contraindication to physical activity.
  • Anticipated unavailability.
  • Severe functional limitation (SPPB ≤ 3).
  • Another health condition requiring priority care.

Eligibility criteria for the formative research:

Inclusion criteria:

People living with HIV:

  • Age ≥40 years
  • Documented HIV infection.
  • Receiving antiretroviral therapy for ≥ 12 months.

Controls:

  • Age ≥40 years
  • Negative HIV test within the last 12 months;
  • Living in Abobo area
  • Written consent to participate to the study

Exclusion Criteria:

Participants living with HIV:

  • HIV infection with HIV-2 type only
  • Any clinical symptoms suggesting an acute infection
  • Any life-threatening pathology in the short term or any pathology not allowing participation in the study

Controls:

  • Any clinical symptoms suggesting an acute infection
  • Any life-threatening pathology in the short term or any pathology not allowing participation in the study

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 3 patient groups

Groupes-based arm
Experimental group
Description:
Participants are invited to participate in group sessions directly supervised by a coach. The other sessions are unsupervised. During the first 24 weeks (active phase), the supervised group sessions are scheduled on a weekly basis while they are more spaced out, on a monthly basis, during the second part of the 48 weeks (maintenance phase).
Treatment:
Behavioral: Physical activity programme
Home-based arm
Experimental group
Description:
Participants have to perform the same exercise programme at home. Start with two weeks of direct supervision to learn how to carry out safely the training and how to adapt the intensity of the exercise using the rated perceived exertion (RPE) and the heart rate self-monitored during exercise.
Treatment:
Behavioral: Home-based physical activity
Control arm
No Intervention group
Description:
Health education session every months.

Trial contacts and locations

2

Loading...

Central trial contact

Anani Badjé; Joseph Tegbe

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems